We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 4.10% | 10.15 | 10.00 | 10.30 | 10.15 | 9.75 | 9.75 | 686,106 | 13:43:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -6.23 | 17.66M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/5/2021 12:17 | yes. Anyone buy that 48.5 call on opti in last two weeks? I didnt because he gets 10 out of 10 wrong always | sentiment riles | |
27/5/2021 12:16 | free-fall possibility | kreature | |
27/5/2021 11:30 | O hara the master? Having a laugh Ray? "Swim once with the shark, you are now its property" | sentiment riles | |
27/5/2021 11:06 | I hate to think PIs in-profit are going to watch those profits erode. Plan your trades, and trade your plan. | notknowing | |
27/5/2021 10:03 | Im just too scared to buy anything on planet earth now, looking at commercialisation standards out there | sentiment riles | |
27/5/2021 09:48 | There should be at least 91 subscribers during initial launch period, if it’s free. More if expenses are paid? | kreature | |
27/5/2021 09:48 | Bullish phase for gerbils [...] — StayOnTop (@Stayontop123On) | sentiment riles | |
27/5/2021 09:36 | First sentence was the funniest lord lolly | sentiment riles | |
27/5/2021 09:28 | I only hold SBTX indirectly through my Opti shares. My take on developments here is that the study results were, as expected, very encouraging. That said, the study size was small (142 suffering from mild to moderate psoriasis). Of these, only 64% (91) completed the study, shaping the results. Regulatory approval is now being sought and will presumably take some time, assuming it's eventually obtained. Commercial launch slated for Q4 '21. Not sure whether approval will come through in that time or if they can "soft launch" without it? Given all this, I'd say the good news was already priced in, as the commercial opportunity & timing remain unknown at this stage (though potentially very large). Probably explains this week's retreat in the share price. Can't see it gaining much ground until company updates on "targeted levels of subscribers during the initial launch period, within 90 days of this (26 May RNS) announcement". | lord loads of lolly | |
27/5/2021 09:23 | Morning all, phase 1 trial passed On to phase 2 [...] — StayOnTop (@Stayontop123On) | sentiment riles | |
27/5/2021 09:20 | Is the £2,000 phone bill refundable ? | kreature | |
27/5/2021 09:06 | Strong support at 15p imo. See chart. | kreature | |
27/5/2021 08:53 | You have the same conviction as SYME, TERN, BIDS, DVRG and many other shareholders. Is SBTX a Jam tomorrow stock? Has there been institutional selling? No products! no sales! like Cellular Goods and ZOE? You can't have it all ways. | notknowing | |
27/5/2021 08:37 | Not knowing is the correct username. The statistical evidence is exceptional. Only a fool would argue otherwise. | slartybartfaster | |
27/5/2021 08:37 | News? Was that not yesterday? | fredd | |
27/5/2021 08:25 | I'm neither long nor short here, but I agree with some of the others that unless there is news imminent to keep punters holding in anticipation, the share price will drift. | notknowing | |
27/5/2021 08:24 | The only conclusion you could maybe draw is that there isn't the demand some might argue exists. If you can't give it away, then what's the chances of selling much of it? | notknowing |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions